Psilocybin trials

The research programme the Trust has funded at Imperial College to test the efficacy of psilocybin as a treatment for depression has finally received all of the required approvals, and can begin recruiting participants. The trial will compare the results of psilocybin, the active ingredient in Magic Mushrooms, against Escitalopram, Read more…

By AMCT, ago